ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near Kansas City, KS, USA:

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Biological: IOV-4001

Phase 1, Phase 2

Iovance Biotherapeutics

Westwood, Kansas, United States and 9 other locations

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: sigvotatug vedotin
Drug: docetaxel

Phase 3

Seagen
Seagen

Kansas City, Missouri, United States and 140 other locations

Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI secondar...

Enrolling
Patients With Non-Small Cell Lung Cancer
Drug: OSE2101
Drug: Docetaxel

Phase 3

OSE Immunotherapeutics
OSE Immunotherapeutics

Merriam, Kansas, United States and 54 other locations

(PK) of BBO-8520, a KRAS G12C (ON) inhibitor, single agent and in combination with pembrolizumab in patients with advanced non-small cell lung...

Enrolling
Colon Cancer
Metastatic Colon Cancer
Drug: BBO-8520
Drug: Pembrolizumab

Phase 1

TheRas, Inc., d/b/a BridgeBio Oncology Therapeutics

Kansas City, Kansas, United States and 14 other locations

in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: encorafenib
Drug: binimetinib

Phase 2

Pfizer
Pfizer

Kansas City, Missouri, United States and 157 other locations

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...

Enrolling
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Livmoniplimab

Phase 2, Phase 3

AbbVie
AbbVie

Westwood, Kansas, United States and 27 other locations

of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung...

Enrolling
Limited-Stage Small Cell Lung Cancer
Drug: carboplatin/cisplatin-etoposide
Drug: Placebo

Phase 3

Henlius Pharmaceuticals

Fairway, Kansas, United States and 128 other locations

improved patient outcomes compared to pembrolizumab alone in patients with previously treated locally advanced or metastatic non-small cell lung...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: CC-486
Drug: Pembrolizumab

Phase 2

Celgene
Celgene

Kansas City, Missouri, United States and 32 other locations

comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) with non-classical or acquired epidermal growth...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Advanced Lung Carcinoma
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Kansas City, Kansas, United States and 24 other locations

IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) tumors that meet protocol-specifie...

Enrolling
Non-small Cell Lung Cancer
Drug: Vemurafenib (Enrollment closed)
Drug: Entrectinib

Phase 2

Genentech
Genentech

Kansas City, Missouri, United States and 33 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems